A Novel Examination of Azithromycin as a Low-Cost Intervention to Achieve Remission in Asthma
- PMID: 39122292
- DOI: 10.1016/j.chest.2024.06.003
A Novel Examination of Azithromycin as a Low-Cost Intervention to Achieve Remission in Asthma
Conflict of interest statement
Financial/Nonfinancial Disclosures The authors have reported to CHEST the following: A. M. has participated in an advisory board for Verona Pharma. None declared (S. L. R.).
Similar articles
-
Comment: cost-effectiveness of macrolides in lower respiratory tract infections.Ann Pharmacother. 2000 Oct;34(10):1206-7. doi: 10.1177/106002800003401001. Ann Pharmacother. 2000. PMID: 11054992 No abstract available.
-
The cost effectiveness of azithromycin for Chlamydia trachomatis infections in women.Sex Transm Dis. 1995 Sep-Oct;22(5):274-80. doi: 10.1097/00007435-199509000-00002. Sex Transm Dis. 1995. PMID: 7502180
-
Azithromycin versus comparative therapy for the treatment of community acquired pneumonia.Int J Antimicrob Agents. 2004 Aug;24(2):181-4. doi: 10.1016/j.ijantimicag.2004.01.011. Int J Antimicrob Agents. 2004. PMID: 15288319 Clinical Trial.
-
Yaws.Br Med Bull. 2015;113(1):91-100. doi: 10.1093/bmb/ldu037. Epub 2014 Dec 18. Br Med Bull. 2015. PMID: 25525120 Free PMC article. Review.
-
Add-on azithromycin reduces sputum cytokines in non-eosinophilic asthma: an AMAZES substudy.Thorax. 2021 Jul;76(7):733-736. doi: 10.1136/thoraxjnl-2020-216331. Epub 2021 Jan 7. Thorax. 2021. PMID: 33414242 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
